Top Markets
Coin of the day
Xspray Pharma AB (publ) Xspray Pharma AB (publ)

Xspray Pharma AB (publ)

XSPRAY
Rang in Aktien #24988
Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden,... Xspray Pharma AB (publ), a pharmaceutical firm based in Solna, Sweden, specializes in developing protein kinase inhibitors for precise cancer treatments. Their current drug pipeline includes HyNap-Nilo, aimed at chronic myeloid leukemia; HyNap-Sora, which targets renal, liver, and several types of thyroid cancer; and HyNap-Dasa, intended for both chronic myeloid leukemia and acute lymphoblastic leukemia. Established in 2003, the company was formerly known as Xspray Microparticles AB until its name change to Xspray Pharma AB (publ) in 2017.
Aktienkurs
$1.19
Marktkapitalisierung
$56.35M
Veränderung (1 Tag)
2.31%
Veränderung (1 Jahr)
-73.10%
Land
SE
Handel Xspray Pharma AB (publ) (XSPRAY)

Kategorie

Kursverlauf für Xspray Pharma AB (publ) (XSPRAY)
Höchster Schlusskurs: $1.45 am 2026-08-01

Niedrigster Schlusskurs: $3.96 am 2017-09-01
Kursverlauf der Aktie von Xspray Pharma AB (publ) von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -10.08%
2025 -16.04%
2024 6.84%
2023 -29.58%
2022 -28.28%
2021 -59.39%
2020 114.77%
2019 11.88%
2018 36.91%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.57 8.46%
CH
$130.43 397.46%
US